Irbesartan 300mg film-coated tablets - blisters is incorrectly labelled as Irbesartan 150mg
Read the official alert on GOV.UK — MedRegWatch re-presents it; GOV.UK is the authoritative source.
| Type | Medicines recall/notification |
|---|---|
| Issued | 23 Dec 2013 |
| Reference | EL (13)A/32 |
| Product licences | PL 20075/0354 |
23 December 2013
Class 2 medicines recall
Action within 48 hours
Class 2 medicines recall
Pharmacy, dispensing clinic and wholesale-level recall
MDR 30-12/13
Product details
Accord Healthcare Limited
Irbesartan 300mg Film-coated Tablets
PL 20075/0354
Alert details
- Batch number: P02924
- Expiry date: January 2015
- Pack size: 2 X 14’s
- First distributed: 11 September 2013
Accord Healthcare Limited is recalling the above batch of Irbesartan 300mg film-coated tablets because the blister foil on a small number of blisters is incorrectly labelled as Irbesartan 150mg. All other labelling is correct and tablets present in the blisters are 300mg strength.
Recipients are requested to quarantine any remaining stock and return it to their supplier for credit.
For stock return enquiries, please contact Accord Healthcare Limited on 0208 8631 427 or email - customerserviceuk@accord-healthcare.com.
For quality or medical information enquiries, please contact Accord Healthcare Limited on 020 8901 3370 or email - safety@lambda-cro.com and uk@accord-healthcare.com.
Recipients of this Drug Alert should bring it to the attention of relevant contacts by copy of this letter. Local area teams are asked to forward this to relevant clinics, general practitioners and community pharmacists for information.